243. Deputy Marie Sherlock asked the Minister for Health if there has been engagement by the corporate pharmaceutical unit in the HSE with the manufacturers of miglustat with regard to juvenile Batten disease; if such medication can be reimbursed for an individual with the life limiting condition on compassionate grounds; and if she will make a statement on the matter. [37963/26]

Summary

243. Deputy Marie Sherlock asked the Minister for Health if there has been engagement by the corporate pharmaceutical unit in the HSE with the manufacturers of miglustat with regard to juvenile Batten disease; if such medication can be reimbursed for an individual with the life limiting condition on compassionate grounds; and if she will make a statement on the matter. [37963/26]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 20 May 2026

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.